Clinical characteristics and prognostic markers in disulfiram-induced liver injury

Journal of Hepatology

Volumn 44, Issue 4, 2006, Pages 791-797

  Björnsson, Einar ^a   Nordlinder, Hans ^a   Olsson, Rolf ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Disulfiram: hepatotoxicity; Drug induced liver injury; Liver transplantation; Mortality

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; DISULFIRAM;

ADULT; CLINICAL FEATURE; CONSENSUS; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG FATALITY; FEMALE; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER BIOPSY; LIVER CELL; LIVER HISTOLOGY; LIVER INJURY; LIVER TOXICITY; LIVER TRANSPLANTATION; LOEFFLER PNEUMONIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL MORTALITY; SWEDEN;

EID: 33644887200     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.12.016     Document Type: Article

References (40)

1. C. Wright, and R.D. Moore Disulfiram treatment of alcoholism. American College of Physicians paper Ann Intern Med 111 1989 943 945
2. C. Brewer Controlled trials of Antabuse in alcoholism: the importance of supervision and adequate dosage Acta Psychiatr Scand 369 1992 51 58
3. G.A. Kenna, J.E. McGeary, and R.M. Swift Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 1 Am J Health Syst Pharm 61 2004 2272 2279
4. G.A. Kenna, J.E. McGeary, and R.M. Swift Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2 Am J Health Syst Pharm 61 2004 2380 2388
5. E.B. Keeffe, and F.W. Smith Disulfiram hypersensitivity J Am Med Assoc 230 1974 435 436
6. H.J. Eisen, and A.L. Ginsberg Letter: disulfiram hepatotoxicity Ann Intern Med 83 1975 673 675
7. L. Ranek, and P. Buch Andreasen Disulfiram hepatotoxicity Br Med J 2 1977 94 96
8. S.J. Morris, R. Kanner, R.O. Chiprut, and E.R. Schiff Disulfiram hepatitis Gastroenterology 75 1978 100 102
9. M.E. Kristensen Toxic hepatitis induced by disulfiram in a non-alcoholic Acta Med Scand 209 1981 335 336
10. W.R. Bartle, M.M. Fisher, and N. Kerenyi Disulfiram-induced hepatitis. Report of two cases and review of the literature Dig Dis Sci 30 1985 834 837
11. R.R. Schade, J.A. Gray, A. Dekker, R.R. Varma, R.D. Shaffer, and D.H. Van Thiel Fulminant hepatitis associated with disulfiram. Report of a case Arch Intern Med 143 1983 1271 1273
12. N.A. Mason Disulfiram-induced hepatitis: case report and review of the literature DICP 23 1989 872 875
13. X. Forns, J. Caballeria, M. Bruguera, J.M. Salmeron, A. Vilella, and A. Mas Disulfiram-induced hepatitis. Report of four cases and review of the literature J Hepatol 21 1994 853 857
14. H. Enghusen Poulsen, S. Loft, J.R. Andersen, and M. Andersen Disulfiram therapy - adverse drug reactions and interactions Acta Psychiatr Scand Suppl 369 1992 59 65
15. L.E. Böttiger, A.K. Furhoff, and L. Holmberg Fatal reactions to drugs Acta Med Scand 205 1979 451 456
16. R. Olsson, G. Brunlöf, M.L. Johansson, and M. Persson Drug-induced hepatic injury in Sweden Hepatology 38 2003 531 532
17. G. Danan, and C. Benichou Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 46 1993 1323 1330
18. C. Benichou, and R. Uclaf Criteria of drug-induced liver disorders. Report of an international consensus meeting J Hepatol 11 1990 272 276
19. Senior JR. Regulatory perspectives. In: Kaplowitz N, DeLeve LD, editors. Drug-induced liver disease; 2003. p. 739-54.
20. C.S. Davidson C.M. Leevy E.C. Chamberlayne Guidelines for detection of hepatotoxicity due to drugs and chemicals [Fogarthy Conference, 1978]. NIH publication No. 79-313 1979 US Government Printing Office Washington, DC
21. E. Björnsson, and R. Olsson Outcome and prognostic markers markers in sever drug-induced liver disease Hepatology 42 2005 481 489
22. R.J. Andrade, M.I. Lucena, M.C. Fernandez, G. Pelaez, K. Pachkoria, and E. Garcia-Ruiz Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period Gastroenterology 129 2005 512 521
23. G.P. Aithal, M.D. Rawlins, and C.P. Day Accuracy of hepatic adverse drug reaction reporting in one English health region Br Med J 319 1999 1541 1544
24. B. Björnsson, A. Bergqvist, P. Jerlstad, and R. Olsson Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden Scand J Gastroenterol 40 2005 1095 1101
25. P.F. Goyer, and L.F. Major Hepatotoxicty in Disulfiram treated patients J Stud Alcohol 40 1979 133 137
26. K. Kaaber, T. Menne, N. Vien, and P. Hougaard Treatment of nickel dermatitis with antabuse: a double blind study Contact Dermatitis 9 1983 297 299
27. C. Wright, R. Moore, D.M. Grodin, D.A. Spyker, and E.V. Gill Screening for disulfiram-induced liver test dysfunction in an in-patient alcoholism program Alcohol Clin Exp Res 17 1993 184 186
28. F. Iber, K. Lee, R. Lacoursiere, and R. Fuller Liver toxicity encountered in the Veterans Administration trial of disulfiram in alcoholics Alcohol Clin Exp Res 11 1987 301 304
29. J. Chick, K. Gough, W. Falkowski, P. Kershaw, B. Hore, and B. Mehta Disulfiram Treat Alcohol 161 1992 84 90
30. J. Chick Safety issues concerning the use of disulfiram in treating alcohol dependence Drug Saf 20 1999 427 435
31. E. Björnsson, H. Nordlinder, and R. Olsson Metronidazol as a probable cause of severe liver injury Hepatogastroenterology 49 2002 252 254
32. E. Björnsson, J. Lindberg, and R. Olsson Liver reactions to oral low-dose tetracyclines Scand J Gastroenterol 32 1997 390 395
33. R. Olsson, B.E. Wiholm, C. Sand, L. Zettergren, R. Hultcrantz, and M. Myrhed Liver damage from flucloxacillin, cloxacillin and dicloxacillin J Hepatol 15 1992 154 161
34. R.G. Berlin Disulfiram hepatotoxicity: a consideration of its mechanism and clinical spectrum Alcohol Alcoholism 24 1989 241 246
35. E. Eliasson, P. Stål, A. Oksanen, and S. Lytton Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis J Hepatol 29 1998 819 825
36. M. Bourdi, D. Larrey, J. Nataf, J. Bernuau, D. Pessayre, and M. Iwasaki Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P450IA2. A specific marker of dihydralazine-induced hepatitis J Clin Invest 85 1990 364 369
37. E. Eliasson, and J.G. Kenna Cytochrome P450 2E1 is a cell surface autoantigen in halthane hepatitis Mol Pharmacol 50 1996 573 582
38. C. Ju Immunological mechansisms of drug-induced liver injury Curr Opin Drug Discov Develop 8 2005 38 43
39. C. Wright, J.A. Vafier, and R. Lake Disulfiram-induced fulminant hepatitis: guidelines for liver-panel monitoring J Clin Psychiatry 49 1988 430 434
40. A.J. Saxon, K.L. Sloan, J. Reoux, and V.H. Haver Disulfiram use in patients with abnormal liver function tests J Clin Psychiatry 59 1998 313 316